SARS-CoV-2 Omicron XBB.1.5 Variant Pseudovirus
Product Specifications
Background
SARS-CoV-2 Omicron Pseudovirus uses HIV pseudotyped with SARS-CoV-2 spike protein and firefly luciferase reporter. This pseudovirus effectively infects human ACE2 overexpressing cells and can be used to screen for inhibitors of Spike-ACE2 interaction, determine neutralizing antibody titers, and is a valuable tool for COVID-19 vaccine development as well.
NCBI Gene ID
43740568
Swiss Prot
P0DTC1
Accession Number
QHD43416
Type
Pseudovirus
Source
HEK293 cells
Field of Research
Infectious Disease, COVID-19
Buffer
DMEM/10% FBS
Shipping Conditions
Dry Ice
Storage Conditions
The pseudovirus is stable in a liquid state at -70˚ for 12 months. Avoid repeated freeze-thaw cycles.
Applications Notes
Click here to download6
NCBI Official Name
Surface glycoprotein
NCBI Organism
Severe acute respiratory syndrome coronavirus 2
Other Product Names
Spike glycoprotein Receptor-binding domain, S glycoprotein, Spike protein, Omicron variant spike, Omicron variant pseudovirus, Omicron, pseudovirus reporter, reporter virus particle
Tested Applications
Neutralization assay, Viral Infection
Species
SARS-CoV-2 (COVID-19) Spike pseudovirus
Protein ID
1791269090
Physical Properties
Liquid
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6397896-01 0.1 mL
UBE3C (Ubiquitin-protein Ligase E3C, HectH2, KIAA0010, KIAA10) (PE)
Sign In for Pricing
View Details MBS6397896-02 5x 0.1 mL
UBE3C (Ubiquitin-protein Ligase E3C, HectH2, KIAA0010, KIAA10) (PE)
Sign In for Pricing
View Details N2305-02F 50 µL
NFKB2 (Nuclear Factor NF-kappa-B p100 Subunit, DNA-binding Factor KBF2, H2TF1, Lymphocyte Translocation Chromosome 10 Protein, Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B Cells 2, Oncogene Lyt-10, LYT10) discontinued
Sign In for Pricing
View Details 